Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · IEX Real-Time Price · USD
1.980
-0.010 (-0.50%)
At close: Jul 19, 2024, 4:00 PM
1.990
+0.010 (0.51%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Stereotaxis Revenue

Stereotaxis had revenue of $27.10M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $6.88M with 5.07% year-over-year growth. In the year 2023, Stereotaxis had annual revenue of $26.77M.

Revenue (ttm)
$27.10M
Revenue Growth
-2.01%
P/S Ratio
6.04
Revenue / Employee
$222,156
Employees
122
Market Cap
163.63M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.77M-1.38M-4.89%
Dec 31, 202228.15M-6.87M-19.63%
Dec 31, 202135.02M8.39M31.51%
Dec 31, 202026.63M-2.27M-7.86%
Dec 31, 201928.90M-444.07K-1.51%
Dec 31, 201829.35M-1.80M-5.77%
Dec 31, 201731.14M-1.02M-3.17%
Dec 31, 201632.16M-5.51M-14.63%
Dec 31, 201537.67M2.66M7.61%
Dec 31, 201435.01M-3.02M-7.94%
Dec 31, 201338.03M-8.53M-18.32%
Dec 31, 201246.56M4.58M10.90%
Dec 31, 201141.99M-12.06M-22.32%
Dec 31, 201054.05M2.90M5.67%
Dec 31, 200951.15M10.78M26.72%
Dec 31, 200840.37M1.07M2.71%
Dec 31, 200739.30M12.11M44.52%
Dec 31, 200627.19M12.17M80.96%
Dec 31, 200515.03M-3.79M-20.14%
Dec 31, 200418.82M13.80M275.22%
Dec 31, 20035.01M5.00M26,433.74%
Dec 31, 200218.90K--
Dec 31, 20010--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 336.45M
Repare Therapeutics 97.86M
TriSalus Life Sciences 21.98M
Syros Pharmaceuticals 6.98M
INmune Bio 131.00K
Revenue Rankings